| Dr Joyce Rii, DO | |
|
13755 Cicero Ave, Crestwood, IL 60445-1824 | |
| (888) 220-6432 | |
| (630) 654-4253 |
| Full Name | Dr Joyce Rii |
|---|---|
| Gender | Female |
| Speciality | Infectious Disease |
| Experience | 18 Years |
| Location | 13755 Cicero Ave, Crestwood, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386891679 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 036121551 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Osf Little Company Of Mary Medical Center | Evergreen park, IL | Hospital |
| Advocate Christ Hospital & Medical Center | Oak lawn, IL | Hospital |
| Advocate Trinity Hospital | Chicago, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Metro Infectious Disease Consultants Llc | 3072425784 | 297 |
News Archive
The science team from Advaxis, Inc., the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, met with the Data Safety Monitoring Board (DSMB), an independent group of medical experts, yesterday and received approval to dose all remaining patients in the initial forty (40) patient leg of the 120-patient, cervical dysplasia clinical trial being conducted in the United States.
Wastewater containing coronaviruses may be a serious threat, according to a new, global study led by researchers from the Zuckerberg Institute for Water Research at Ben-Gurion University of the Negev (BGU).
Cell Therapeutics, Inc. announced today that CTI received a statement on March 1, 2010 from the Gynecologic Oncology Group (GOG) leadership that the phase III GOG-212 clinical trial of CTI's OPAXIO™ used as maintenance therapy for ovarian cancer remains a high priority and enrollment will continue. The GOG made the statement to clarify that the recent results of the GOG-218 clinical trial bevacizumab in maintenance therapy for ovarian cancer has not influenced the importance of completing the GOG-212 clinical trial.
Meanwhile, new research from the Center for Studying Health System Change indicates that more small businesses may be self-insuring - a step that will reduce their participation in the health law's insurance exchanges.
› Verified 4 days ago
| Entity Name | Metro Infectious Disease Consultants Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235125717 PECOS PAC ID: 3072425784 Enrollment ID: O20031103000274 |
News Archive
The science team from Advaxis, Inc., the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, met with the Data Safety Monitoring Board (DSMB), an independent group of medical experts, yesterday and received approval to dose all remaining patients in the initial forty (40) patient leg of the 120-patient, cervical dysplasia clinical trial being conducted in the United States.
Wastewater containing coronaviruses may be a serious threat, according to a new, global study led by researchers from the Zuckerberg Institute for Water Research at Ben-Gurion University of the Negev (BGU).
Cell Therapeutics, Inc. announced today that CTI received a statement on March 1, 2010 from the Gynecologic Oncology Group (GOG) leadership that the phase III GOG-212 clinical trial of CTI's OPAXIO™ used as maintenance therapy for ovarian cancer remains a high priority and enrollment will continue. The GOG made the statement to clarify that the recent results of the GOG-218 clinical trial bevacizumab in maintenance therapy for ovarian cancer has not influenced the importance of completing the GOG-212 clinical trial.
Meanwhile, new research from the Center for Studying Health System Change indicates that more small businesses may be self-insuring - a step that will reduce their participation in the health law's insurance exchanges.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joyce Rii, DO 901 Mc Clintock Drive, Suite 202, Burr Ridge, IL 60527-0872 Ph: (888) 220-6432 | Dr Joyce Rii, DO 13755 Cicero Ave, Crestwood, IL 60445-1824 Ph: (888) 220-6432 |
News Archive
The science team from Advaxis, Inc., the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, met with the Data Safety Monitoring Board (DSMB), an independent group of medical experts, yesterday and received approval to dose all remaining patients in the initial forty (40) patient leg of the 120-patient, cervical dysplasia clinical trial being conducted in the United States.
Wastewater containing coronaviruses may be a serious threat, according to a new, global study led by researchers from the Zuckerberg Institute for Water Research at Ben-Gurion University of the Negev (BGU).
Cell Therapeutics, Inc. announced today that CTI received a statement on March 1, 2010 from the Gynecologic Oncology Group (GOG) leadership that the phase III GOG-212 clinical trial of CTI's OPAXIO™ used as maintenance therapy for ovarian cancer remains a high priority and enrollment will continue. The GOG made the statement to clarify that the recent results of the GOG-218 clinical trial bevacizumab in maintenance therapy for ovarian cancer has not influenced the importance of completing the GOG-212 clinical trial.
Meanwhile, new research from the Center for Studying Health System Change indicates that more small businesses may be self-insuring - a step that will reduce their participation in the health law's insurance exchanges.
› Verified 4 days ago
Kamo G Sidhwa, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 13755 Cicero Ave, Crestwood, IL 60445 Phone: 888-220-6432 Fax: 630-654-4253 | |
Dr. Sejal Kalawadia, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 13755 Cicero Ave, Crestwood, IL 60418 Phone: 708-388-0499 Fax: 708-388-0283 | |
Malak Elsheikh, M.B.B.S Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 13755 Cicero Ave, Crestwood, IL 60418 Phone: 888-220-6432 | |
Dr. Sheila Margaret Barry, M.D./PH.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 13755 S Cicero Ave, Crestwood, IL 60445 Phone: 888-220-6432 Fax: 630-654-4253 | |
Dr. Sampath P Kumar, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 13755 Cicero Ave, Crestwood, IL 60445 Phone: 888-220-6432 Fax: 708-385-7840 | |
Dr. Daniel C Desimone, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 13755 Cicero Ave, Crestwood, IL 60418 Phone: 708-972-7642 Fax: 708-925-9179 |